Comorbidities & Multisystem Impact — Account for the impact of comorbidities and multisystem involvement during examination. - National Physical Therapy Examination NPTE

SECTION 1

Historical Context & Motivation

For much of the twentieth century, rehabilitation professionals approached patient care through a lens that prioritized the primary diagnosis—a single condition driving the plan of care. A patient presenting with a fractured hip, for instance, would receive interventions targeting musculoskeletal recovery with relatively little systematic attention to coexisting conditions such as diabetes mellitus, heart failure, or chronic obstructive pulmonary disease (COPD). As the population aged and chronic disease prevalence rose, clinicians began to recognize that these coexisting conditions—termed comorbidities—profoundly influenced examination findings, treatment tolerance, and patient outcomes. The shift toward a multisystem examination framework represents one of the most significant paradigm changes in physical therapy practice.

1980 • WHO International Classification of Impairments

The World Health Organization publishes the International Classification of Impairments, Disabilities, and Handicaps (ICIDH), laying groundwork for understanding how multiple conditions interact to affect function.

1995 • Nagi Disablement Model Adopted

The APTA formally adopts a disablement framework that encourages clinicians to consider pathology, impairment, functional limitation, and disability as interconnected domains, prompting attention to how comorbidities affect each level.

2001 • ICF Framework Published

The WHO's International Classification of Functioning, Disability and Health (ICF) replaces the ICIDH, explicitly acknowledging that body functions, activities, participation, and contextual factors—including comorbid conditions—interact dynamically.

2014 • APTA Guide to Physical Therapist Practice 3.0

The updated Guide emphasizes systems review across cardiovascular/pulmonary, integumentary, musculoskeletal, and neuromuscular systems during every patient encounter, formalizing multisystem screening as standard practice.

2020s • Complexity Science and Multimorbidity

Growing recognition that multimorbidity—having two or more chronic conditions—is the norm rather than the exception among adult patients, with over 60% of adults over age 65 managing multiple chronic diseases simultaneously.

The central question this lesson addresses is both clinical and conceptual: How do coexisting pathologies across multiple body systems alter the physical therapy examination, modify expected findings, and influence clinical decision-making? Mastering this competency is essential for the NPTE, where examination questions frequently present patients with layered medical histories that demand integrative reasoning rather than isolated problem-solving.

SECTION 2

Core Principles & Definitions

Before examining specific system interactions, it is essential to establish the foundational concepts that govern how physical therapists approach patients with multiple active conditions. The distinction between comorbidity and multimorbidity is clinically meaningful: comorbidity refers to additional conditions coexisting alongside a defined primary or index condition, whereas multimorbidity describes the simultaneous presence of two or more chronic conditions without designating any single one as primary. In physical therapy practice, both terms compel the clinician to conduct a thorough systems review and modify examination strategies accordingly.

Systems Review

A brief, systematic screening of the cardiovascular/pulmonary, integumentary, musculoskeletal, and neuromuscular systems conducted during every initial examination to identify potential comorbid involvement that may affect the plan of care.

Red & Yellow Flags

Red flags indicate findings that warrant immediate medical referral (e.g., uncontrolled blood pressure, acute neurological change). Yellow flags are psychosocial or systemic factors—including comorbidities—that may slow recovery or complicate treatment.

Differential Diagnosis Considerations

Comorbidities may mimic, mask, or amplify findings from the primary condition. For example, peripheral neuropathy from diabetes may obscure proprioceptive deficits caused by a concurrent vestibular disorder.

Exercise Tolerance & Vital Sign Monitoring

Comorbid cardiovascular or pulmonary conditions alter exercise capacity. Monitoring heart rate, blood pressure, oxygen saturation, and rate of perceived exertion becomes critical when prescribing therapeutic exercise intensity.

Medication Effects on Examination

Medications for comorbid conditions—beta-blockers, anticoagulants, corticosteroids, opioids—can alter heart rate response, bleeding risk, tissue healing, and cognition, directly affecting examination findings and safety parameters.

✦

KEY TAKEAWAY

Think of comorbidity screening like pre-flight checks on an aircraft. A pilot does not only inspect the engines before takeoff—they verify hydraulics, avionics, fuel systems, and weather conditions because a failure in any single system can compromise the entire flight. Similarly, a physical therapist who examines only the musculoskeletal system while ignoring cardiovascular, neurological, or integumentary status risks missing critical factors that will determine whether the patient can safely participate in rehabilitation and achieve meaningful outcomes.

SECTION 3

Visual Explanation — Multisystem Interaction Map

This interaction map illustrates the four primary body systems screened during the systems review (cardiovascular/pulmonary, neuromuscular, musculoskeletal, integumentary) and their bidirectional influence on the patient examination. Dashed lines represent cross-system pathways—such as exercise tolerance linking cardiopulmonary to musculoskeletal function—that comorbidities can disrupt.

The diagram above serves as a clinical reasoning scaffold. When you encounter an NPTE question describing a patient with both congestive heart failure and lumbar spinal stenosis, you should visualize how the cardiovascular/pulmonary box connects to the musculoskeletal box through the exercise tolerance pathway. The heart failure limits cardiac output during ambulation training, the spinal stenosis restricts lumbar extension and walking distance, and together these conditions create a compounding effect on functional mobility that neither condition alone would predict. Similarly, a patient with diabetes and a pressure ulcer demonstrates the integumentary-neuromuscular link: peripheral neuropathy impairs protective sensation, which delays wound recognition and healing. Effective examination requires you to trace these cross-system pathways and anticipate how findings in one domain alter your clinical decisions in another.

SECTION 4

How Comorbidities Alter the Examination Process

Physiological Mechanisms of Multisystem Interaction

Comorbidities do not simply coexist in isolation within the body—they interact through shared physiological pathways that amplify impairments and create novel clinical presentations. Understanding these mechanisms is essential for accurately interpreting examination findings. Three primary mechanisms govern how comorbidities alter the physical therapy examination: shared pathophysiology, pharmacological cross-effects, and functional compounding.

Shared Pathophysiology

Many chronic conditions share underlying mechanisms such as systemic inflammation, endothelial dysfunction, or autonomic dysregulation. A patient with type 2 diabetes and peripheral artery disease, for example, demonstrates how hyperglycemia-induced endothelial damage accelerates atherosclerotic plaque formation, simultaneously worsening cardiovascular risk and impairing peripheral perfusion. During examination, the therapist may observe diminished pedal pulses, delayed capillary refill, and reduced exercise tolerance—findings that reflect the convergent pathophysiology of both conditions. Interpreting these findings in isolation would lead to incomplete clinical reasoning.

Pharmacological Cross-Effects

Medications prescribed for comorbid conditions frequently alter the parameters that physical therapists measure. Beta-adrenergic blockers blunt the heart rate response to exercise, rendering traditional target heart rate formulas unreliable. Anticoagulants such as warfarin increase bleeding risk, requiring modified manual therapy techniques and heightened awareness of bruising or hematoma during soft tissue examination. Corticosteroids used for inflammatory conditions can cause osteoporosis, skin fragility, and impaired wound healing, all of which must be factored into integumentary assessment and exercise prescription.

Functional Compounding

Even when two conditions do not share a direct pathophysiological link, their combined effect on function can be greater than the sum of their individual impacts. Consider a patient with both Parkinson disease and osteoarthritis of the knee. The Parkinson disease contributes bradykinesia, rigidity, and postural instability, while the osteoarthritis adds pain, joint stiffness, and reduced range of motion. Together, these conditions create a fall risk that far exceeds what either condition would generate independently. The therapist must recognize that gait examination findings—shortened stride length, festinating pattern overlaid with antalgic compensation—reflect the interaction of both conditions, not a single pathology.

💡

NPTE Clinical Pearl

When an NPTE question presents a patient on beta-blockers, remember that heart rate cannot be used as the primary indicator of exercise intensity. Instead, use the Rating of Perceived Exertion (RPE) scale (Borg 6–20 or modified 0–10) and blood pressure response to monitor exercise tolerance. An appropriate RPE target is typically 11–14 on the Borg scale ("fairly light" to "somewhat hard").

SECTION 5

Detailed Breakdown — Common System Interactions

To prepare for the NPTE, clinicians must be able to rapidly identify how specific comorbid pairings alter examination priorities, expected findings, and safety precautions. The following diagram and table detail the most commonly tested multisystem interactions on the examination.

Six common comorbidity pairings are shown with their key examination implications. Below, the four-step decision framework illustrates how clinicians should systematically approach multisystem examination: identify all diagnoses, map their interactions, modify examination parameters, and continuously monitor and reassess throughout the plan of care.

Comorbidity Pairing	System Interaction	Key Examination Modifications
Diabetes + PAD	Metabolic ↔ Cardiovascular: hyperglycemia damages endothelium; atherosclerosis reduces peripheral perfusion	Perform monofilament testing, ABI measurement, pedal pulse assessment; inspect feet every visit; avoid aggressive stretching of ischemic tissue
CHF + COPD	Cardiac ↔ Pulmonary: reduced cardiac output combined with impaired gas exchange severely limits oxygen delivery	Monitor SpO₂ continuously; use RPE rather than HR for intensity; assess for peripheral edema and jugular venous distension; modify rest intervals
CKD + Hypertension	Renal ↔ Cardiovascular: impaired kidney function worsens fluid balance and electrolyte regulation, exacerbating hypertension	Monitor BP before, during, and after exercise; be aware of dialysis schedule and fluid shifts; watch for signs of hyperkalemia (muscle weakness, arrhythmia)
Obesity + OA	Metabolic ↔ Musculoskeletal: excess body mass increases joint loading by 3–5× per pound during weight-bearing; adipose tissue releases inflammatory cytokines	Assess gait with consideration of altered biomechanics; screen for sleep apnea and metabolic syndrome; consider non-weight-bearing exercise options; monitor skin folds for breakdown
Depression + Chronic Pain	Psychological ↔ Neurological: shared neurochemical pathways (serotonin, norepinephrine) and central sensitization amplify pain perception	Use validated outcome measures for both pain (NPRS, VAS) and psychological status (PHQ-9); incorporate fear-avoidance beliefs questionnaire; set patient-centered goals; use graded exposure approach

Common comorbidity pairings and their examination implications for the NPTE

SECTION 6

Worked Example — Multisystem Examination Reasoning

The following case demonstrates the systematic process of accounting for comorbidities during a physical therapy examination, as would be expected on the NPTE.

ℹ

Patient Scenario

A 68-year-old female is referred to outpatient physical therapy following a right total knee arthroplasty (TKA). Her medical history includes type 2 diabetes mellitus (A1C = 8.2%), congestive heart failure (NYHA Class II), and peripheral neuropathy in bilateral lower extremities. Current medications include metformin, lisinopril, carvedilol (a beta-blocker), and gabapentin.

Multisystem Examination Reasoning

1
Step 1 — Identify All Active Diagnoses and Medications

Begin by listing all known conditions: (1) status post right TKA (primary diagnosis, musculoskeletal), (2) type 2 diabetes mellitus with elevated A1C (metabolic/endocrine), (3) CHF NYHA Class II (cardiovascular), (4) peripheral neuropathy (neuromuscular). Then review medications: metformin (may cause lactic acidosis during intense exercise), lisinopril (ACE inhibitor, may cause orthostatic hypotension), carvedilol (beta-blocker, blunts HR response), gabapentin (may cause dizziness and sedation).

Four active system involvements identified; four medication effects to monitor
2
Step 2 — Map Cross-System Interactions

The diabetes and peripheral neuropathy interact: neuropathy impairs protective sensation in the feet, increasing risk of undetected skin breakdown at the surgical site and contralateral foot. The diabetes and CHF interact: hyperglycemia worsens endothelial function and fluid retention, compounding cardiac insufficiency. The CHF limits exercise tolerance, directly affecting the intensity and duration of post-TKA rehabilitation. The carvedilol blunts heart rate, making traditional Karvonen formula targets unreliable. The gabapentin may impair balance, which is already compromised by neuropathy and post-surgical pain.

At least five significant cross-system interactions identified
3
Step 3 — Modify Examination Parameters

For the cardiovascular/pulmonary system: monitor BP (supine and standing to check for orthostatic hypotension from lisinopril), SpO₂, and RPE rather than HR during all exercise testing. For the integumentary system: inspect surgical incision, check bilateral feet for ulceration or pressure areas, and perform Semmes-Weinstein monofilament testing to quantify protective sensation loss. For the neuromuscular system: assess proprioception and balance using both static (Romberg) and dynamic (Timed Up and Go) measures, accounting for gabapentin's sedative effects. For the musculoskeletal system: standard post-TKA assessment of ROM, strength, and gait, but with modified intensity parameters due to CHF.

Use RPE 11–13 for exercise intensity; perform integumentary checks every visit; assess balance with fall-risk awareness
4
Step 4 — Establish Red Flag Criteria

Define specific thresholds that warrant stopping exercise or making a medical referral: (1) BP response > 20 mmHg systolic drop upon standing (orthostatic hypotension), (2) SpO₂ < 90% during activity, (3) blood glucose < 70 mg/dL or > 300 mg/dL before exercise, (4) new onset peripheral edema suggesting CHF exacerbation, (5) signs of wound infection (increased erythema, warmth, drainage, fever). Document these thresholds in the plan of care.

Five specific red flag thresholds established for ongoing monitoring
5
Step 5 — Document and Communicate

Document the multisystem examination findings in an integrated format that clearly links comorbid findings to modifications in the plan of care. Communicate with the referring physician regarding the elevated A1C and its implications for wound healing. Consider referral to a certified diabetes educator if blood glucose management is poor. Coordinate with cardiology if CHF symptoms worsen during rehabilitation progression.

Interprofessional communication ensures safe, coordinated multisystem management

SECTION 7

Strengths & Limitations of Multisystem Examination

A comprehensive multisystem approach to examination offers substantial clinical benefits, but it also introduces challenges related to time, complexity, and scope of practice. Understanding both sides is critical for clinical practice and for answering NPTE questions that test your judgment about when and how to integrate comorbidity screening.

Strengths	Limitations
Improves patient safety by identifying red flags that a system-specific examination would miss (e.g., undiagnosed hypertension discovered during routine BP monitoring)	Requires additional time during initial evaluation, which may conflict with productivity demands in clinical settings
Enables more accurate prognosis by accounting for how comorbidities affect recovery timelines and functional outcomes	Clinicians may lack specialized knowledge in all body systems, particularly in areas like endocrinology or nephrology, requiring interprofessional consultation
Supports evidence-based exercise prescription by integrating cardiovascular, metabolic, and musculoskeletal parameters into a unified approach	Risk of information overload: excessive screening without clear clinical reasoning can lead to unfocused examinations and delayed treatment initiation
Facilitates interprofessional communication by producing documentation that reflects the patient's full clinical picture	Scope of practice considerations: PTs must distinguish between screening (within scope) and diagnosing comorbid conditions (outside scope)
Reduces adverse events by proactively identifying medication effects, vital sign abnormalities, and contraindications before they cause harm	Limited standardized protocols exist for multisystem screening in PT; clinicians often rely on clinical judgment rather than validated algorithms

Comparative strengths and limitations of the multisystem examination approach

✦

KEY TAKEAWAY

The multisystem examination approach is analogous to how an engineer conducts a structural integrity assessment of a building after an earthquake. The engineer does not merely inspect the damaged wing—they evaluate the foundation, electrical systems, plumbing, and adjacent structures because damage in one area often propagates through interconnected systems. In the same way, a physical therapist who identifies only the musculoskeletal impairment without screening cardiovascular, neurological, and integumentary systems risks building a rehabilitation plan on an unstable foundation. The NPTE rewards clinicians who demonstrate this integrative reasoning.

SECTION 8

Connection to Advanced Clinical Reasoning

The concepts covered in this lesson form the foundation for more advanced clinical reasoning models that you will encounter in clinical practice and on the NPTE. As you progress from basic comorbidity awareness to sophisticated multisystem management, the complexity of decision-making increases substantially. The table below contrasts the foundational skills covered here with the advanced competencies expected of practicing clinicians.

Foundational Competency	Advanced Application
Identify comorbidities from the medical record and patient interview	Screen for undiagnosed conditions through pattern recognition (e.g., identifying signs of undiagnosed diabetes in a patient presenting with bilateral carpal tunnel syndrome and recurrent infections)
Modify vital sign monitoring based on known medications	Integrate pharmacokinetics into exercise timing (e.g., scheduling therapy sessions to coincide with peak medication efficacy for Parkinson disease patients on levodopa)
Recognize when comorbidities alter expected examination findings	Use hypothesis-oriented clinical reasoning (HOAC) to generate and test competing hypotheses about which condition is driving specific findings
Apply red flag criteria to determine when to refer to other providers	Manage complex patients across care settings (acute, subacute, outpatient, home health) with condition-specific protocols that dynamically adjust as the patient's multisystem status evolves
Document comorbid findings in the examination record	Lead interprofessional care conferences, synthesizing findings from multiple disciplines to create integrated management plans that address all active conditions simultaneously

Progression from foundational to advanced multisystem clinical reasoning

The NPTE increasingly tests clinical scenarios that require you to operate at the intersection of foundational and advanced competencies. Questions may present patients with three or more active conditions and ask you to prioritize examination components, identify the most significant interaction, or determine the safest exercise prescription. The ability to rapidly synthesize multisystem information—rather than treating each condition independently—distinguishes competent entry-level clinicians from those who are merely knowledgeable about individual pathologies. As the healthcare landscape continues to shift toward managing an aging, multimorbid population, this integrative skill set becomes not just academically valuable but clinically indispensable.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A physical therapist is performing an initial examination on a 72-year-old male referred for balance training following a fall. His medical history includes type 2 diabetes, hypertension, and benign prostatic hyperplasia. He takes metformin, amlodipine, and tamsulosin. Which medication is MOST likely to directly affect the physical therapist's examination findings related to his primary referral diagnosis of balance impairment?

Show answer

Tamsulosin (an alpha-adrenergic blocker used for benign prostatic hyperplasia) is the most likely medication to directly affect balance examination findings because alpha-blockers commonly cause orthostatic hypotension—a significant and treatable contributor to falls and balance impairment. While amlodipine can also lower blood pressure, tamsulosin's alpha-blocking mechanism has a more pronounced effect on postural blood pressure regulation. During the examination, the therapist should perform orthostatic vital sign measurements (supine to sitting to standing) to determine whether medication-induced hypotension is contributing to the patient's fall risk, which would alter both the examination findings and the treatment approach.

Question 2: BASIC CALCULATION

A 55-year-old female with CHF (NYHA Class II) and a resting heart rate of 72 bpm is prescribed carvedilol. Her age-predicted maximum heart rate using the formula 220 − age = 165 bpm. Using the Karvonen formula with a target intensity of 60%, what would the calculated target heart rate be? Then explain why this calculation is clinically inappropriate for this patient.

Show answer

Using the Karvonen formula: Target HR = [(HRmax − HRrest) × intensity] + HRrest = [(165 − 72) × 0.60] + 72 = [93 × 0.60] + 72 = 55.8 + 72 = 127.8 bpm, approximately 128 bpm. However, this calculation is clinically inappropriate for two reasons. First, carvedilol is a non-selective beta-blocker that attenuates the heart rate response to exercise, meaning the patient's actual maximal heart rate will be significantly lower than 165 bpm, rendering the age-predicted maximum invalid. Second, her CHF limits cardiac output independently of heart rate. The appropriate alternative is to use the Rating of Perceived Exertion (RPE) scale, targeting a Borg score of 11–13, combined with blood pressure monitoring and SpO₂ assessment to guide exercise intensity safely.

Question 3: INTERMEDIATE

A 65-year-old male presents to outpatient physical therapy with a primary diagnosis of right rotator cuff repair (4 weeks post-operative). His comorbidities include type 2 diabetes (A1C = 9.1%), obesity (BMI = 34), and chronic kidney disease (Stage 3). During the initial examination, which components of the systems review should be PRIORITIZED beyond the standard musculoskeletal assessment, and what specific findings would prompt a modification to the plan of care or a medical referral?

Show answer

Beyond the standard musculoskeletal assessment of the rotator cuff repair, the therapist should prioritize: (1) Integumentary system—inspect the surgical incision for signs of delayed healing or infection, which are significantly more likely with an A1C of 9.1% (indicating poorly controlled diabetes). A1C values above 8.0% are associated with impaired wound healing, increased infection risk, and may warrant communication with the surgeon regarding healing expectations. (2) Cardiovascular system—monitor blood pressure closely due to CKD Stage 3, which impairs fluid regulation. Check for peripheral edema as a sign of fluid retention. (3) Metabolic screening—check blood glucose before exercise; values below 70 or above 300 mg/dL are contraindications to exercise. The CKD-obesity-diabetes triad creates a compounding metabolic burden. Specific findings prompting referral include: incision site erythema with drainage (surgeon referral), blood pressure consistently above 180/110 mmHg at rest (medical referral), new peripheral edema suggesting CKD progression (nephrology referral), or blood glucose values indicating loss of metabolic control.

Question 4: APPLIED

A physical therapist in a skilled nursing facility is evaluating a 78-year-old female admitted after a left CVA with right hemiparesis. Her comorbidities include atrial fibrillation (on warfarin, INR = 3.8), osteoporosis (T-score = −3.2), and major depressive disorder (on sertraline). During the examination, the therapist notes a large bruise on the patient's right hip that the patient does not recall sustaining. How should the therapist integrate these multisystem findings to guide examination decisions and determine the appropriate course of action?

Show answer

This case requires integration of at least four system considerations. First, the INR of 3.8 is above the typical therapeutic range of 2.0–3.0 for atrial fibrillation, indicating supratherapeutic anticoagulation. This explains the unexplained bruise but also raises the risk of internal hemorrhage. The therapist should immediately communicate this finding to the nursing staff and physician, as the elevated INR requires medical management. Second, the combination of osteoporosis (T-score of −3.2, well below the −2.5 threshold) and supratherapeutic anticoagulation means that even a minor fall or aggressive manual therapy technique could cause a fracture with subsequent hemorrhagic complications. The therapist must use extreme caution with transfers and should consider radiographic evaluation of the bruised hip to rule out occult fracture. Third, the right hemiparesis from the CVA means the bruised right side has reduced voluntary motor control and diminished protective responses, explaining how an injury could occur without the patient's awareness. Fourth, the depression and sertraline may impair motivation and contribute to psychomotor retardation, affecting the patient's participation in rehabilitation. Sertraline may also increase bleeding risk when combined with warfarin. The examination should include gentle balance and transfer assessment with close supervision, integumentary inspection of all bony prominences, cognitive screening to assess safety awareness, and fall risk assessment. The therapist should withhold aggressive mobilization activities until the INR is within therapeutic range and communicate urgently with the medical team about the INR finding.

Question 5: CRITICAL THINKING

A physical therapist is developing an examination plan for a 60-year-old male with the following conditions: Parkinson disease (Hoehn and Yahr Stage 3), type 2 diabetes with peripheral neuropathy, COPD (GOLD Stage 2), and lumbar spinal stenosis. He takes carbidopa/levodopa, metformin, insulin glargine, tiotropium inhaler, and gabapentin. Construct a prioritized examination framework that accounts for all comorbid interactions, explain which cross-system interactions create the greatest risk, and describe how you would sequence the examination to maximize patient safety while obtaining the most clinically valuable information.

Show answer

This patient presents with four major system involvements creating numerous interactions. The greatest risk interactions are: (1) Parkinson disease + peripheral neuropathy = severe fall risk due to impaired postural reflexes compounded by loss of protective sensation and proprioception; (2) COPD + Parkinson disease = restrictive and obstructive ventilatory compromise due to chest wall rigidity from Parkinson overlaid on airflow limitation from COPD, severely limiting exercise capacity; (3) Insulin + exercise = hypoglycemia risk, especially given that the patient may have impaired hypoglycemia awareness due to autonomic dysfunction from both Parkinson disease and diabetic neuropathy. The examination should be sequenced as follows. First, check blood glucose and vital signs (HR, BP supine/standing, SpO₂, respiratory rate) before initiating any physical examination—this establishes baseline safety. Schedule the examination 60–90 minutes after carbidopa/levodopa administration when the medication is at peak efficacy, as Parkinson symptoms will be most controlled during this window. Second, perform the integumentary screen (foot inspection, surgical site check if applicable) while the patient is seated, which is low-demand and allows continued vital sign recovery. Third, conduct seated neuromuscular assessment including tone, coordination, sensation (monofilament, vibration, proprioception), and cranial nerve screening. Fourth, progress to standing balance assessment (Romberg, single-leg stance, functional reach) with standby assist and gait belt. Fifth, perform the gait analysis incorporating the Six-Minute Walk Test, monitoring SpO₂ throughout and using RPE due to the unreliability of HR with autonomic dysfunction. Assess for both Parkinsonian gait features (festination, freezing) and neurogenic claudication from the spinal stenosis (symptom reproduction with walking, relief with flexion). Throughout the examination, monitor for orthostatic hypotension (common in Parkinson disease and exacerbated by levodopa), respiratory distress (dyspnea, accessory muscle use, SpO₂ drops), hypoglycemic symptoms (diaphoresis, confusion, tremor—which may be difficult to distinguish from Parkinsonian tremor), and gabapentin-related sedation or dizziness. Document all findings with explicit links between comorbid conditions and their combined functional impact. This systematic approach maximizes safety by front-loading the least physically demanding assessments and progressively increasing demands while continuously monitoring multisystem responses.

SUMMARY

Comorbidities & Multisystem Impact — Summary

Summary

Accounting for comorbidities and multisystem involvement during the physical therapy examination is a foundational clinical competency tested throughout the NPTE. The systems review—covering cardiovascular/pulmonary, integumentary, musculoskeletal, and neuromuscular domains—serves as the gateway to identifying conditions that alter examination findings and treatment parameters. Three primary mechanisms drive multisystem interactions: shared pathophysiology (e.g., endothelial damage linking diabetes and cardiovascular disease), pharmacological cross-effects (e.g., beta-blockers blunting heart rate response), and functional compounding (e.g., Parkinson disease combined with osteoarthritis creating fall risk beyond what either condition predicts alone).

Clinicians must follow a systematic four-step framework: identify all diagnoses, map cross-system interactions, modify examination parameters (including using RPE instead of HR targets for patients on beta-blockers, checking blood glucose before exercise for diabetic patients, and performing integumentary inspection for patients with neuropathy), and monitor and reassess throughout the plan of care. Recognizing red flags—such as supratherapeutic INR, uncontrolled blood pressure, or signs of wound infection—and knowing when to refer to other providers is as important as the physical examination itself. Mastery of these integrative skills prepares you not only for NPTE success but for safe, effective clinical practice with the complex, multimorbid patients who constitute the majority of the rehabilitation population.